298 related articles for article (PubMed ID: 15717029)
1. Biomarkers and surrogate outcomes in neurodegenerative disease: lessons from multiple sclerosis.
Miller DH
NeuroRx; 2004 Apr; 1(2):284-94. PubMed ID: 15717029
[TBL] [Abstract][Full Text] [Related]
2. The role of magnetic resonance techniques in understanding and managing multiple sclerosis.
Miller DH; Grossman RI; Reingold SC; McFarland HF
Brain; 1998 Jan; 121 ( Pt 1)():3-24. PubMed ID: 9549485
[TBL] [Abstract][Full Text] [Related]
3. Targeting progressive neuroaxonal injury: lessons from multiple sclerosis.
Bar-Or A; Rieckmann P; Traboulsee A; Yong VW
CNS Drugs; 2011 Sep; 25(9):783-99. PubMed ID: 21870889
[TBL] [Abstract][Full Text] [Related]
4. Characterization of tissue damage in multiple sclerosis by nuclear magnetic resonance.
Barkhof F; van Walderveen M
Philos Trans R Soc Lond B Biol Sci; 1999 Oct; 354(1390):1675-86. PubMed ID: 10603619
[TBL] [Abstract][Full Text] [Related]
5. MRI measures of neuroprotection and repair in multiple sclerosis.
Inglese M
J Neurol Sci; 2011 Dec; 311 Suppl 1():S16-23. PubMed ID: 22206761
[TBL] [Abstract][Full Text] [Related]
6. Evidence for early neurodegeneration in the cervical cord of patients with primary progressive multiple sclerosis.
Abdel-Aziz K; Schneider T; Solanky BS; Yiannakas MC; Altmann DR; Wheeler-Kingshott CA; Peters AL; Day BL; Thompson AJ; Ciccarelli O
Brain; 2015 Jun; 138(Pt 6):1568-82. PubMed ID: 25863355
[TBL] [Abstract][Full Text] [Related]
7. Sodium accumulation is associated with disability and a progressive course in multiple sclerosis.
Paling D; Solanky BS; Riemer F; Tozer DJ; Wheeler-Kingshott CA; Kapoor R; Golay X; Miller DH
Brain; 2013 Jul; 136(Pt 7):2305-17. PubMed ID: 23801742
[TBL] [Abstract][Full Text] [Related]
8. MRI as an outcome in multiple sclerosis clinical trials.
Daumer M; Neuhaus A; Morrissey S; Hintzen R; Ebers GC
Neurology; 2009 Feb; 72(8):705-11. PubMed ID: 19073945
[TBL] [Abstract][Full Text] [Related]
9. Cervical Cord T1-weighted Hypointense Lesions at MR Imaging in Multiple Sclerosis: Relationship to Cord Atrophy and Disability.
Valsasina P; Aboulwafa M; Preziosa P; Messina R; Falini A; Comi G; Filippi M; Rocca MA
Radiology; 2018 Jul; 288(1):234-244. PubMed ID: 29664341
[TBL] [Abstract][Full Text] [Related]
10. Relevance of spinal cord abnormalities to clinical disability in multiple sclerosis: MR imaging findings in a large cohort of patients.
Lukas C; Sombekke MH; Bellenberg B; Hahn HK; Popescu V; Bendfeldt K; Radue EW; Gass A; Borgwardt SJ; Kappos L; Naegelin Y; Knol DL; Polman CH; Geurts JJ; Barkhof F; Vrenken H
Radiology; 2013 Nov; 269(2):542-52. PubMed ID: 23737540
[TBL] [Abstract][Full Text] [Related]
11. Brain and cord myelin water imaging: a progressive multiple sclerosis biomarker.
Kolind S; Seddigh A; Combes A; Russell-Schulz B; Tam R; Yogendrakumar V; Deoni S; Sibtain NA; Traboulsee A; Williams SC; Barker GJ; Brex PA
Neuroimage Clin; 2015; 9():574-80. PubMed ID: 26594633
[TBL] [Abstract][Full Text] [Related]
12. Role of MRI in multiple sclerosis II: brain and spinal cord atrophy.
Zivadinov R; Bakshi R
Front Biosci; 2004 Jan; 9():647-64. PubMed ID: 14766398
[TBL] [Abstract][Full Text] [Related]
13. Chronic white matter lesion activity predicts clinical progression in primary progressive multiple sclerosis.
Elliott C; Belachew S; Wolinsky JS; Hauser SL; Kappos L; Barkhof F; Bernasconi C; Fecker J; Model F; Wei W; Arnold DL
Brain; 2019 Sep; 142(9):2787-2799. PubMed ID: 31497864
[TBL] [Abstract][Full Text] [Related]
14. MR imaging intensity modeling of damage and repair in multiple sclerosis: relationship of short-term lesion recovery to progression and disability.
Meier DS; Weiner HL; Guttmann CR
AJNR Am J Neuroradiol; 2007; 28(10):1956-63. PubMed ID: 17998417
[TBL] [Abstract][Full Text] [Related]
15. MRI evidence for multiple sclerosis as a diffuse disease of the central nervous system.
Filippi M; Rocca MA
J Neurol; 2005 Nov; 252 Suppl 5():v16-24. PubMed ID: 16254697
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance imaging measures of brain atrophy in multiple sclerosis.
Anderson VM; Fox NC; Miller DH
J Magn Reson Imaging; 2006 May; 23(5):605-18. PubMed ID: 16596564
[TBL] [Abstract][Full Text] [Related]
17. Magnetization transfer ratio measures in normal-appearing white matter show periventricular gradient abnormalities in multiple sclerosis.
Liu Z; Pardini M; Yaldizli Ö; Sethi V; Muhlert N; Wheeler-Kingshott CA; Samson RS; Miller DH; Chard DT
Brain; 2015 May; 138(Pt 5):1239-46. PubMed ID: 25823475
[TBL] [Abstract][Full Text] [Related]
18. Gray matter T2 hypointensity is related to plaques and atrophy in the brains of multiple sclerosis patients.
Bakshi R; Dmochowski J; Shaikh ZA; Jacobs L
J Neurol Sci; 2001 Mar; 185(1):19-26. PubMed ID: 11266686
[TBL] [Abstract][Full Text] [Related]
19. In vivo characterization of cortical and white matter neuroaxonal pathology in early multiple sclerosis.
Granberg T; Fan Q; Treaba CA; Ouellette R; Herranz E; Mangeat G; Louapre C; Cohen-Adad J; Klawiter EC; Sloane JA; Mainero C
Brain; 2017 Nov; 140(11):2912-2926. PubMed ID: 29053798
[TBL] [Abstract][Full Text] [Related]
20. Deficient MWF mapping in multiple sclerosis using 3D whole-brain multi-component relaxation MRI.
Kitzler HH; Su J; Zeineh M; Harper-Little C; Leung A; Kremenchutzky M; Deoni SC; Rutt BK
Neuroimage; 2012 Feb; 59(3):2670-7. PubMed ID: 21920444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
